Dopamine transporter binding in symptomatic controls and healthy volunteers: Considerations for neuroimaging trials

OBJECTIVE: To evaluate possible differences between brain dopamine transporter (DAT) binding in a group of symptomatic parkinsonism patients without dopaminergic degeneration and healthy individuals. BACKGROUND: Dopaminergic neuroimaging studies of Parkinson’s disease (PD) have often used control gr...

Descripción completa

Detalles Bibliográficos
Autores principales: Honkanen, Emma A., Eklund, Mikael, Nuuttila, Simo, Noponen, Tommi, Jaakkola, Elina, Mäkinen, Elina, Hirvilammi, Risto, Seppänen, Marko, Lindholm, Kari, Scheperjans, Filip, Parkkola, Riitta, Joutsa, Juho, Varrone, Andrea, Kaasinen, Valtteri
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Regular Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8416950/
https://www.ncbi.nlm.nih.gov/pubmed/34482280
http://dx.doi.org/10.1016/j.nicl.2021.102807

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8416950/
https://www.ncbi.nlm.nih.gov/pubmed/34482280
http://dx.doi.org/10.1016/j.nicl.2021.102807

Ejemplares similares